Papers/PMID:23137858
Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)2013The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
Zn(2+) — decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“In the overall analysis, a small but statistically significant reduction in fasting glucose concentrations was observed (-0.19±0.08mmol/L, P=0.013) after zinc supplementation.”
Quoted verbatim from Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans.. - Study
- meta-analysis
- Population
- Participants in fourteen randomised placebo-controlled zinc supplementation trials, pooled overall analysis (healthy and chronic metabolic disease)
Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans.2013PMID:23137858Permalink